PipelinePharma Logo

Generics 9

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tafamidis manufacturers

9 products found

Filters

9 products found

tafamidis

Capsules 61 mg, 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Dossier availability date: Q2 2024 for 61 mg, 2025 for 20 mg
Manufacturer #21467

Manufacturer usually replies in 9 days

tafamidis

Capsules 20 mg, 61 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Comments
Tafamidis free acid - 61 mg;Tafamidis meglumine - 20 mg
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

tafamidis

Capsules 61 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Cardiomyopathy; Status: Q2 2024 Under Development
Manufacturer #385

A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 10 days

tafamidis + meglumine

Oral solution 10 mg/ml , 20 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #31060

Manufacturer usually replies in nan days

tafamidis

Capsules 20 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP, TGA
Comments
Pilot BE passed
Manufacturer #21891

Manufacturer usually replies in 5 days

tafamidis

Capsules 20 mg

Dossier type
US CTD
Dossier status
Under development
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP, TGA
Comments
Exhibit batch planned for Oct’24 Pilot BE passed
Manufacturer #21891

Manufacturer usually replies in 5 days

tafamidis

Capsules 20 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
Bangladesh
GMP approvals
FDA, EU GMP, TGA
Comments
Pilot BE passed
Manufacturer #21891

Manufacturer usually replies in 5 days

tafamidis

Tablets 20 mg, 61 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #32970

Manufacturer usually replies in 9 days

tafamidis

Capsules 61 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers